HB
REGN icon

Horizon Bancorp’s Regeneron Pharmaceuticals REGN Stock Holding History

Horizon Bancorp’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$162K Buy
289
+28
+11% +$17K 0.23% 123
2020
Q2 		$163K Buy
+261
New +$148K 0.18% 124

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Horizon Bancorp's REGN Position: Q3 2020 in Review

Horizon Bancorp increased its Regeneron Pharmaceuticals (REGN) stake by 11% in Q3 2020, buying an estimated $17K and bringing the position to 289 shares worth $162K. The position accounts for 0.23% of the portfolio, ranked #123.

Horizon Bancorp first reported a position in REGN in Q2 2020 and has held it in 2 quarters since. The position peaked at $163K in Q2 2020. 907 funds tracked by Wall St. Rank hold REGN as of Q3 2020.

  • Horizon Bancorp held 289 shares of Regeneron Pharmaceuticals worth $162K as of Q3 2020.
  • Horizon Bancorp bought 28 Regeneron Pharmaceuticals shares in Q3 2020, an estimated $17K.
  • Regeneron Pharmaceuticals made up 0.23% of Horizon Bancorp's portfolio in Q3 2020, its #123 holding.
  • Horizon Bancorp first reported a position in Regeneron Pharmaceuticals in Q2 2020 and has held it in 2 quarters since.
  • Horizon Bancorp's Regeneron Pharmaceuticals position peaked at $163K in Q2 2020.
  • 907 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2020.

Based on Horizon Bancorp's 13F filing for Q3 2020, filed 12 Nov 2020.